SCHEMBL4159674

SCHEMBL4159674

CC(=O)NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NCC(O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
CES1 P23141 6/20 0.42
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
FAAH O00519 4/20 0.36
CES2 O00748 2/20 0.36
PLA2G6 O60733 1/20 0.36
POLB P06746 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
ASAH1 Q13510 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
BCAT2 O15382 1/20 0.33
GLS O94925 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4163608 0.83 CES1 (0.54) HDAC1HDAC2CES1FAAHCES2
SCHEMBL4160443 0.76 KDM4E (0.39) HDAC1HDAC2CES1ALDH1A1NPC1
SCHEMBL4158065 0.76 CES1 (0.45) HDAC1HDAC2CES1ALDH1A1BCAT2
SCHEMBL4606757 0.75 HDAC1 (0.41) HDAC1HDAC2CES1SMN1; SMN2ALDH1A1
Trifluoroacetic Acid SCHEMBL4158022 0.75 HDAC1 (0.38) HDAC1HDAC2CES1SMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL4166172 0.74 SIRT2 (0.41) HDAC1HDAC2CES1FAAHGLS
SCHEMBL4161122 0.74 NPC1 (0.46) HDAC1HDAC2CES1SMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL4168691 0.74 CHRM2 (0.41)
SCHEMBL4152045 0.73 ALDH1A1 (0.41) HDAC1HDAC2CES1SMN1; SMN2ALDH1A1
SCHEMBL4154036 0.72 CES1 (0.42) HDAC1HDAC2CES1SMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 HDAC1 2/4885HDAC2 7/4885CES1 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.